2011 - Validation of Analytical Methods and Procedures
Date2011-12-08
Deadline2011-12-08
VenueVirtual, USA - United States
KeywordsPharmaceutical; FDA; validation
Topics/Call fo Papers
This seminar will discuss how to design, conduct and document validation of analytical methods for FDA compliance.
Why to attend:
Analytical methods should be validated to ensure reliability, consistency and accuracy of analytical data. This seminar will discuss FDA and equivalent international requirements and provide several Warning Letters for non-compliance. This seminar will go through all steps on how to design, conduct and document method validation experiments for efficiency and compliance. Attendees will receive a toolkit with SOPs, Case Studies and Examples for easy implementation.
Areas Covered in the Seminar:
* FDA regulations and guidelines
* Examples of warning letters and how to avoid them
* USP Chapters and ICH Guides
* Developing an SOP for method validation
* Development of a validation plan for success
* Prerequisites for method validation
* Defining the minimum number of validation experiments that satisfy ICH, FDA and USP
* Defining test conditions and acceptance limits
* Verification of compendial methods
* To revalidate or not after method changes
* Transferring a method to routine
*?Seven most common method validation pitfalls and how to avoid them
* Documentation for the FDA and for other agencies
Date: December 8,2011
Time: 11.00 - 12.00 a.m. EST
Location: Online, worldwide (oder USA, nicht Germany, fall das möglich ist)
Who should attend
* (Bio) Pharmaceutical and API Industry
* Food, environmental, clinical, and chemical testing laboratories
* QA managers and personnel
* Analysts and lab managers
* Validation specialists
* Training departments
* Documentation department
* Consultants
Weblink: http://www.labcompliance.com/seminars/audio/280/de...
Presenter: Dr. Ludwig Huber
Category: Pharmaceutical, FDA, validation
Why to attend:
Analytical methods should be validated to ensure reliability, consistency and accuracy of analytical data. This seminar will discuss FDA and equivalent international requirements and provide several Warning Letters for non-compliance. This seminar will go through all steps on how to design, conduct and document method validation experiments for efficiency and compliance. Attendees will receive a toolkit with SOPs, Case Studies and Examples for easy implementation.
Areas Covered in the Seminar:
* FDA regulations and guidelines
* Examples of warning letters and how to avoid them
* USP Chapters and ICH Guides
* Developing an SOP for method validation
* Development of a validation plan for success
* Prerequisites for method validation
* Defining the minimum number of validation experiments that satisfy ICH, FDA and USP
* Defining test conditions and acceptance limits
* Verification of compendial methods
* To revalidate or not after method changes
* Transferring a method to routine
*?Seven most common method validation pitfalls and how to avoid them
* Documentation for the FDA and for other agencies
Date: December 8,2011
Time: 11.00 - 12.00 a.m. EST
Location: Online, worldwide (oder USA, nicht Germany, fall das möglich ist)
Who should attend
* (Bio) Pharmaceutical and API Industry
* Food, environmental, clinical, and chemical testing laboratories
* QA managers and personnel
* Analysts and lab managers
* Validation specialists
* Training departments
* Documentation department
* Consultants
Weblink: http://www.labcompliance.com/seminars/audio/280/de...
Presenter: Dr. Ludwig Huber
Category: Pharmaceutical, FDA, validation
Other CFPs
- Cost Effective Computer System Validation: Step-by-Step
- Learning from Recent Warning Letters Related to Computer Validation and Part 11
- 2011 International Conference on Communication and Network Security
- 2012 58th IEEE Pulp and Paper Industry Conference - PPIC
- 2011 11th International Conference on Inorganic Scintillators and their Applications (SCINT 2011)
Last modified: 2011-09-08 19:52:15